Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort
Authors:
- Andrew D. Md SchreinerAndrew D. Md Schreiner
- Sherry Ma LivingstonSherry Ma Livingston
- Jingwen ZhangJingwen Zhang
- Mulugeta GebregziabherMulugeta Gebregziabher
- Justin Bs MarsdenJustin Bs Marsden
- David G. Md KochDavid G. Md Koch
- Chelsey A. PetzChelsey A. Petz
- Valerie L. Durkalski-MauldinValerie L. Durkalski-Mauldin
- Patrick D. MauldinPatrick D. Mauldin
- William P. MoranWilliam P. Moran
- 22 July 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 57 (1) , 89-96
Abstract
Goals and Background: Using natural language processing to create a nonalcoholic fatty liver disease (NAFLD) cohort in primary care, we assessed advanced fibrosis risk with the Fibrosis-4 Index (FIB-4) and NAFLD Fibrosis Score (NFS) and evaluated risk score agreement. Materials and Methods: In this retrospective study of adults with radiographic evidence of hepatic steatosis, we calculated patient-level FIB-4 and NFS scores and categorized them by fibrosis risk. Risk category and risk score agreement was analyzed using weighted κ, Pearson correlation, and Bland-Altman analysis. A multinomial logistic regression model evaluated associations between clinical variables and discrepant FIB-4 and NFS results. Results: Of the 767 patient cohorts, 71% had a FIB-4 or NFS score in the indeterminate-risk or high-risk category for fibrosis. Risk categories disagreed in 43%, and scores would have resulted in different clinical decisions in 30% of the sample. The weighted κ statistic for risk category agreement was 0.41 [95% confidence interval (CI): 0.36-0.46] and the Pearson correlation coefficient for log FIB-4 and NFS was 0.66 (95% CI: 0.62-0.70). The multinomial logistic regression analysis identified black race (odds ratio=2.64, 95% CI: 1.84-3.78) and hemoglobin A1c (odds ratio=1.37, 95% CI: 1.23-1.52) with higher odds of having an NFS risk category exceeding FIB-4. Conclusions: In a primary care NAFLD cohort, many patients had elevated FIB-4 and NFS risk scores and these risk categories were often in disagreement. The choice between FIB-4 and NFS for fibrosis risk assessment can impact clinical decision-making and may contribute to disparities of care.Keywords
This publication has 33 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care SettingAmerican Journal of Gastroenterology, 2015
- Gaps in Recognition and Evaluation of Incidentally Identified Hepatic SteatosisDigestive Diseases and Sciences, 2014
- Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated dataAlimentary Pharmacology & Therapeutics, 2014
- Prevalence of Childhood and Adult Obesity in the United States, 2011-2012JAMA, 2014
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseGut, 2010
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Assessing Validity of ICD‐9‐CM and ICD‐10 Administrative Data in Recording Clinical Conditions in a Unique Dually Coded DatabaseHealth Services Research, 2008
- FIB-4Hepatology, 2007
- The NAFLD fibrosis scoreHepatology, 2007
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡Hepatology, 2006